NOD2 Expression in Streptococcus pneumoniae Meningitis and Its Influence on the Blood-Brain Barrier

Ying Wang1,2, Xinjie Liu1, Qi Liu2

  • 1Department of Pediatrics, Qilu Hospital, Shandong University, 107# Wen Hua Xi Road, Jinan, Shandong 250012, China.

Insights

Nucleotide-binding oligomerization domain 2 (NOD2) and inflammatory factors increase in Streptococcus pneumoniae meningitis, potentially damaging the blood-brain barrier (BBB). This research highlights NOD2's role in meningitis pathogenesis and BBB disruption.

Area of Science:

  • Neuroscience
  • Immunology
  • Infectious Diseases

Background:

  • Streptococcus pneumoniae meningitis is a common clinical disorder.
  • Brain immune injury is linked to pattern-recognition receptor (PRR) expression, inducing inflammatory cascades.
  • The role of NOD2 in pneumococcal meningitis and its effect on blood-brain barrier (BBB) integrity requires further investigation.

Purpose of the Study:

  • To investigate the expression of nucleotide-binding oligomerization domain 2 (NOD2) and inflammatory factors in rat brain tissues during Streptococcus pneumoniae meningitis.
  • To determine the influence of NOD2 and inflammatory factors on blood-brain barrier (BBB) permeability.
  • To elucidate the role of NOD2 in the pathogenesis of Streptococcus pneumoniae meningitis.

Main Methods:

  • Streptococcus pneumoniae meningitis rat models were established via intracranial injection.
  • Expression levels of NOD2 and inflammatory factors (IL-1β, TNF-α, IL-6) were measured using ELISA, Western blotting, and qRT-PCR at various time points.
  • Pathological characteristics, neurological scores, cerebral edema, and BBB permeability were assessed, with NOD2 expression visualized by immunohistochemistry (IHC).

Main Results:

  • NOD2 expression increased significantly starting at 12 hours post-infection.
  • Marked elevation of NOD2, IL-1β, TNF-α, and IL-6 levels occurred at 24 and 48 hours, correlating with increased BBB permeability.
  • Positive NOD2 expression was confirmed in infected rat brain tissues via IHC.

Conclusions:

  • NOD2 expression is upregulated during Streptococcus pneumoniae meningitis and may contribute to inflammation.
  • NOD2 and associated inflammatory factors play a significant role in the pathogenesis of pneumococcal meningitis.
  • The study suggests a link between NOD2 activation, inflammatory pathways, and blood-brain barrier damage in this condition.

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
53.1K
Cranial and Spinal Meninges01:19

Cranial and Spinal Meninges

The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
4.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
900
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
822
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K